Last updated: February 20, 2026
Haloperidol lactate is an antipsychotic medication used primarily for schizophrenia, acute psychosis, and Tourette syndrome. It is available via multiple suppliers globally, either as a branded product or through generic manufacturers.
Major Manufacturers and Suppliers
| Manufacturer/Supplier |
Manufacturing Location |
Product Name(s) |
Formulation & Packaging |
Market Presence |
| Johnson & Johnson (Janssen) |
United States, Europe |
Haldol® Decanoate, Haldol® Lactate |
Injectable ampoules, vials |
Market leader in branded drugs |
| Teva Pharmaceutical Industries |
Israel, global |
Generic Haloperidol Lactate |
Vials, ampoules |
Extensive global distribution |
| Sandoz (Novartis) |
Switzerland, global |
Generic Haloperidol Lactate |
Ampoules, vials |
Broad international reach |
| Mylan (now part of Viatris) |
United States, India |
Generic formulations |
Ampoules, vials |
Wide supply chain |
| Sun Pharmaceutical Industries |
India, global |
Generic Haloperidol Lactate |
Ampoules, vials |
Growing market presence |
| Lupin Pharmaceuticals |
India |
Generic formulations |
Ampoules, vials |
Specific regional markets |
| Aurobindo Pharma |
India, global |
Generic Haloperidol Lactate |
Injectable forms |
Focus on Asia and emerging markets |
Regulatory Status & Approvals
- United States: Approved by the FDA as Haldol® and generics; available in injectable forms.
- European Union: Approved medicines include Janssen's Haldol® Lactate and generics.
- India: Multiple formulations approved via DCGI, including from Aurobindo, Sun, and Lupin.
- Other Markets: Approvals granted through respective national regulatory agencies; however, formulation and branding vary.
API (Active Pharmaceutical Ingredient) Suppliers
Many manufacturers source haloperidol lactate API from third-party API suppliers. Top API producers include:
- Voncea (Italy)
- Hetero Labs (India)
- Aarti Industries (India)
- Hubei Topfer Pharmaceutical (China)
API quality standards follow ICH guidelines, with most APIs manufactured under GMP conditions.
Distribution Channels
- Drug Wholesalers: Major pharmaceutical distributors in North America, Europe, and Asia supply hospitals and clinics.
- Generic Suppliers: Marketed through authorized generics and third-party pharmacies.
- OEM Companies: Contract manufacturers produce under licensing agreements for larger firms.
Market Dynamics
- The generic market accounts for over 85% of global haloperidol lactate sales, driven by patent expirations of branded formulations.
- Price competition remains intense, especially in emerging markets where multiple generic firms compete.
- Supply chains are susceptible to regional API production costs, regulatory hurdles, and geopolitical issues.
Key Considerations for Procurement
- Regulatory compliance: Ensure supplier certifications meet local GMP standards.
- Supply stability: Confirm multiple sourcing options to mitigate disruptions.
- Pricing: Negotiate bulk purchase agreements, especially in high-volume markets.
- Quality standards: Verify batch release testing, stability data, and documentation.
Summary
Major suppliers include Johnson & Johnson, Teva, Sandoz, Mylan, and Sun Pharma. The API market is served predominantly by Indian, Chinese, and European producers, with generic formulations dominating the market landscape. The supply chain's robustness depends on regulatory compliance, API sourcing, and regional distribution channels.
Key Takeaways
- The global market for haloperidol lactate revolves around a few key branded and numerous generic manufacturers.
- Generic drugs account for the majority of market share, driven by patent expiration.
- Multiple API suppliers exist, mainly in India, China, and Europe.
- Regulatory and quality compliance are critical factors affecting supplier choice.
- Supply chain resilience depends on diversified sourcing and adherence to GMP standards.
FAQs
1. Who are the main global suppliers of haloperidol lactate?
Johnson & Johnson, Teva, Sandoz, Mylan, and Sun Pharma.
2. What formulations of haloperidol lactate are available?
Injectable vials and ampoules are most common, used in hospital settings.
3. Where is the API for haloperidol lactate predominantly produced?
India, China, and Europe.
4. How does the market for generic haloperidol lactate compare to branded?
Generics make up roughly 85% or more of sales due to patent expiration and cost considerations.
5. What are key factors when sourcing haloperidol lactate?
Regulatory compliance, supply stability, API quality, and price.
References
[1] U.S. Food and Drug Administration. (2023). Haldol® (haloperidol) Drug Details.
[2] European Medicines Agency. (2022). Market authorization for haloperidol.
[3] Indian regulatory agencies. (2023). List of approved generic formulations.
[4] IQVIA. (2022). Global Generic Market Reports.
[5] API Supplier Certifications and Industry Reports.
